Cellebrite DI Ltd

Cellebrite DI Ltd(CLBT)股票分析

$11.370

+0.230 (+2.02%)收盤時

Loading chart…
最高
11.430
開盤
11.240
成交量加權均價
11.31
成交量
1.27M
市值
2.43B
最低
11.125
成交金額
14.40M
企業價值/稅息折舊攤銷前利潤(TTM)
46.95

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.

AI 分析 of Cellebrite DI Ltd (CLBT)

持有

Cellebrite DI Ltd is not a strong buy right now due to its current price of $11.03, which is significantly below the average analyst price target of $20. However, the stock has shown a 21% year-over-year growth in annual recurring revenue, indicating potential for recovery. The main risk is the recent earnings miss with an EPS surprise of -44.44%, suggesting that the company's financial performance may not meet investor expectations in the near term.

估值指標

Cellebrite DI Ltd(CLBT)目前預期本益比為 35.71,5 年平均預期本益比為 41.20。

預期本益比

合理
5 年均值 P/E
41.20
目前P/E
35.71
高估
57.35
低估
25.06

預期 EV/EBITDA

高估
5 年均值 EV/EBITDA
30.08
目前EV/EBITDA
46.95
高估
42.34
低估
17.81

預期股價營收比

合理
5 年均值 P/S
5.64
目前P/S
4.33
高估
7.91
低估
3.38

Alphio AI 對 CLBT 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CLBT

$24.00

情境價格

基

基準

基準 · 50%CLBT

$20.91

情境價格

悲

悲觀

悲觀 · 25%CLBT

$20.21

情境價格

持有 CLBT 的大戶

P

Phoenix Investments & Finances Ltd

+ 持有CLBT

+5.88%

3個月報酬率

P

Portolan Capital Management, LLC

+ 持有CLBT

-1.27%

3個月報酬率

V

Voss Capital, LP

+ 持有CLBT

-1.67%

3個月報酬率

W

Weiss Asset Management, LLC

+ 持有CLBT

-3.11%

3個月報酬率

C

Clal Financial Management Ltd

+ 持有CLBT

-8.87%

3個月報酬率

事件時間軸

2026-09-14 (ET)

08:30:00

Cellebrite Board Approves Corporate Reorganization Plan

2026-09-02 (ET)

09:00:00

Cellebrite Guardian Achieves IRAP Certification

2026-08-13 (ET)

16:30:00

Major Averages Rise as Oil Prices Fall

12:30:00

Cellebrite Shares Drop 31.8% to $10.40

12:00:00

Major Averages Rise as Oil Prices Fall

資訊

CLBT 常見問題 —— 由 Alphio AI 解答

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. It operates in the Technology sector.

Cellebrite DI Ltd is not a strong buy right now due to its current price of $11.03, which is significantly below the average analyst price target of $20. However, the stock has shown a 21% year-over-year growth in annual recurring revenue, indicating potential for recovery. The main risk is the recent earnings miss with an EPS surprise of -44.44%, suggesting that the company's financial performance may not meet investor expectations in the near term.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易